Takeda Pharmaceutical Limited
TAK | NYSE
$19
+$0.11 (+0.58%)
Sep 22, 2026, 12:15 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Mar 30, 2026 | FY 2024 Mar 30, 2025 | FY 2023 Mar 30, 2024 | FY 2022 Mar 30, 2023 | FY 2021 Mar 30, 2022 | FY 2020 Mar 30, 2021 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 597.63B | 385.11B | 457.8B | 533.53B | 849.7B | 966.22B |
Short-Term Investments | n/a | 20.48B | 15.09B | 20.17B | 25.31B | 36.6B |
Long-Term Investments | 450.68B | 361.93B | 430.61B | 378.86B | 330.13B | 348.35B |
Other Long-Term Assets | 77.34B | 70.28B | 51.21B | 63.33B | 82.61B | 100.34B |
Receivables | 880.15B | 725.25B | 697.61B | 681.69B | 724.38B | 812.71B |
Inventory | 1.4T | 1.22T | 1.21T | 986.46B | 853.17B | 753.88B |
Other Current Assets | 223.45B | 173B | 178.21B | 176.1B | 141.1B | 143.48B |
Total Current Assets | 3.1T | 2.52T | 2.56T | 2.4T | 2.59T | 2.71T |
Property-Plant & Equipment | 2.13T | 1.97T | 1.99T | 1.69T | 1.58T | 1.45T |
Goodwill & Intangibles | 9.27T | 8.96T | 9.68T | 9.06T | 8.23T | 7.94T |
Total Long-Term Assets | 12.42T | 11.73T | 12.55T | 11.56T | 10.58T | 10.2T |
Total Assets | 15.52T | 14.25T | 15.11T | 13.96T | 13.18T | 12.91T |
Account Payables | 493.48B | 308.45B | 319.96B | 307.45B | 295.93B | 232.11B |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 514.38B | 548.94B | 367.25B | 339.6B | 203.99B | 22.15B |
Other Current Liabilities | 1.33T | 1.35T | 1.29T | 1.26T | 1.22T | 1.26T |
Total Current Liabilities | 2.44T | 2.51T | 2.31T | 2.48T | 2.15T | 1.77T |
Long-Term Debt | 4.39T | 3.97T | 4.48T | 4.04T | 4.14T | 4.61T |
Other Long-Term Liabilities | 856B | 804.37B | 931.41B | 807.78B | 755.84B | 805.87B |
Total Long-Term Liabilities | 5.27T | 4.81T | 5.52T | 5.12T | 5.35T | 5.96T |
Total Liabilities | 7.71T | 7.31T | 7.83T | 7.6T | 7.49T | 7.74T |
Total Debt | 4.9T | 4.52T | 4.84T | 4.38T | 4.35T | 4.64T |
Book Value | 7.81T | 6.94T | 7.27T | 6.35T | 5.68T | 5.18T |
Book Value Per Share | 2.44K | 2.16K | 2.3K | 2.02K | 1.8K | 1.65K |
Common Stock | 1.7T | 1.69T | 1.68T | 1.68T | 1.68T | 1.67T |
Retained Earnings | 1.06T | 1.19T | 1.39T | 1.54T | 1.48T | 1.51T |
Comprehensive Income | 3.31T | 2.35T | 2.51T | 1.51T | 934.17B | 366.11B |
Shareholders Equity | 7.81T | 6.94T | 7.27T | 6.35T | 5.68T | 5.17T |
Total Investments | 450.68B | 382.4B | 445.7B | 399.03B | 355.44B | 384.95B |
Add to Watchlist
Select watchlists to add or remove TAK